Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ElectromedCyclopharmImricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIBMedica GroupMRI Interventions
Price Information
Current Price$13.29A$1.36A$1.38GBX 129.50N/A
52 Week RangeBuyN/AN/AHoldN/A
Beat the Market™ Rank
Overall Score0.
Analysis Score1.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationBuyN/AN/AHoldN/A
Consensus Price Target$12.00N/AN/AGBX 119N/A
% Upside from Price Target-9.71% downsideN/AN/A-8.11% downsideN/A
Trade Information
Market Cap$131.49 million$106.40 million$154.68 million£131.81 million$52.92 million
Average Volume149,742N/AN/A235,60463,036
Sales & Book Value
Annual RevenueN/A$17.01 million$639,704.00£46.54 millionN/A
Price / SalesN/A6.34242.683.09N/A
CashflowN/AA$0.16 per shareA$0.05 per shareGBX 15.44 per shareN/A
Price / CashN/A8.4025.568.39N/A
Book ValueN/AA$0.30 per shareA$0.08 per shareGBX 32.30 per shareN/A
Price / BookN/A4.5818.160.04N/A
Net IncomeN/AN/AN/AN/AN/A
EPSN/AA($0.04)A($0.22)GBX 7.10N/A
Trailing P/E Ratio0.00N/AN/A18.240.00
Forward P/E RatioN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutN/AA$0.01N/AGBX 0.02N/A
Dividend YieldN/A0.74%N/A0.02%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A N/A0.28%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/A21.21%28.04%34.72%N/A
Current RatioN/A5.64%4.78%5.57%N/A
Quick RatioN/A4.85%3.73%5.45%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding8.48 million79.26 million112.50 million111.11 million15.21 million
Next Earnings Date8/25/2020 (Estimated)N/AN/AN/A8/3/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.